NACDS Addresses DIR Fees, Other “Access Agenda” Priorities in National Drug-Pricing Policy Discussion NACDS responds to request-for-information from HHS Secretary Azar for “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs”

2018-07-18T16:25:32+00:00Jul-18-18|Categories: Press Release|Tags: , , , , |

NACDS has submitted comments to Health and Human Services Secretary Alex Azar in response to the agency’s request-for-information on drug-pricing public policy issues.

NACDS RxIMPACT Rallies Senate Support for Action on DIR Fees Urging Senators to sign letter to HHS Secretary is the most recent action of NACDS’ grassroots advocacy program on this pressing issue

2018-07-11T12:20:12+00:00Jul-11-18|Categories: Press Release|Tags: , , , , |

NACDS RxIMPACT pharmacy advocates are urging Senators to sign a letter to U.S. Secretary of Health and Human Services Secretary Alex Azar that is being led by Sen. Shelley Moore Capito (R-WV) and Sen. Jon Tester (D-MT).

NACDS Comments to CMS on Medicare Prescription Drug Program Urges Medicare Part D policies related to DIR fee fairness, opioid abuse prevention, prescription drug affordability, and patients’ pharmacy access

2018-01-17T09:58:38+00:00Jan-17-18|Categories: Press Release|Tags: , |

NACDS expressed support for, and provided further input, on CMS’ proposed rule, which involves issues including direct and indirect remuneration fees; e-prescribing; medication therapy management; opioid abuse; and fostering pharmacy access.

NACDS Conveys Pharmacy “Access Agenda” Themes in The Hill Op-ed describes commitment to patient care, policy solutions and collaboration

2017-06-15T13:06:34+00:00Mar-14-17|Categories: Press Release|Tags: , , , , , |

Arlington, VA – In a column published in today’s print and online editions of The Hill, the National Association of Chain Drug Stores (NACDS) positioned pharmacy patient care and collaboration across […]

Load More Posts